Published in

Taylor and Francis Group, Expert Review of Pharmacoeconomics and Outcomes Research, 3(18), p. 297-304, 2018

DOI: 10.1080/14737167.2018.1421459

Links

Tools

Export citation

Search in Google Scholar

Most important barriers and facilitators of HTA usage in decision-making in Europe

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Red circle
Preprint: archiving forbidden
Orange circle
Postprint: archiving restricted
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO